LadRx Corp. Appoints New CEO, Board Changes
Ticker: LADX · Form: 8-K · Filed: Apr 16, 2025 · CIK: 799698
| Field | Detail |
|---|---|
| Company | Ladrx Corp (LADX) |
| Form Type | 8-K |
| Filed Date | Apr 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, executive-compensation, board-of-directors
TL;DR
New CEO Dr. Steven G. Deitcher takes over at LadRx Corp. as Dr. Richard L. Schilsky exits the board.
AI Summary
On April 14, 2025, LadRx Corp. announced changes in its board of directors and executive compensation. Dr. Steven G. Deitcher has been appointed as the new Chief Executive Officer and President, effective immediately. The company also reported the departure of Dr. Richard L. Schilsky from the board of directors.
Why It Matters
This filing indicates a significant leadership transition at LadRx Corp., with a new CEO taking the helm and a board member departing, which could signal a shift in the company's strategic direction.
Risk Assessment
Risk Level: medium — Leadership changes and executive compensation adjustments can introduce uncertainty and impact future performance.
Key Players & Entities
- LadRx Corp. (company) — Registrant
- Dr. Steven G. Deitcher (person) — Appointed CEO and President
- Dr. Richard L. Schilsky (person) — Departed Board of Directors
- April 14, 2025 (date) — Effective date of changes
FAQ
Who has been appointed as the new CEO and President of LadRx Corp.?
Dr. Steven G. Deitcher has been appointed as the new Chief Executive Officer and President of LadRx Corp.
When did the changes in leadership and board composition take effect?
The changes took effect on April 14, 2025.
Who has departed from the LadRx Corp. board of directors?
Dr. Richard L. Schilsky has departed from the board of directors of LadRx Corp.
What is the exact name of the company filing this report?
The exact name of the company is LadRx Corporation.
What is the principal executive office address for LadRx Corp.?
The principal executive office address is 11726 San Vicente Boulevard, Suite 650, Los Angeles, California 90049.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2025 by Dr. Steven G. Deitcher regarding LadRx Corp (LADX).